Display options
Share it on

Biomed Res Int. 2015;2015:406463. doi: 10.1155/2015/406463. Epub 2015 Feb 19.

A miRNA-driven inference model to construct potential drug-disease associations for drug repositioning.

BioMed research international

Hailin Chen, Zuping Zhang

Affiliations

  1. School of Software, East China Jiaotong University, Nanchang 330013, China ; Intelligent Optimization & Information Processing Lab, East China Jiaotong University, Nanchang 330013, China.
  2. School of Information Science and Engineering, Central South University, Changsha 410083, China.

PMID: 25789319 PMCID: PMC4350970 DOI: 10.1155/2015/406463

Abstract

Increasing evidence discovered that the inappropriate expression of microRNAs (miRNAs) will lead to many kinds of complex diseases and drugs can regulate the expression level of miRNAs. Therefore human diseases may be treated by targeting some specific miRNAs with drugs, which provides a new perspective for drug repositioning. However, few studies have attempted to computationally predict associations between drugs and diseases via miRNAs for drug repositioning. In this paper, we developed an inference model to achieve this aim by combining experimentally supported drug-miRNA associations and miRNA-disease associations with the assumption that drugs will form associations with diseases when they share some significant miRNA partners. Experimental results showed excellent performance of our model. Case studies demonstrated that some of the strongly predicted drug-disease associations can be confirmed by the publicly accessible database CTD (www.ctdbase.org), which indicated the usefulness of our inference model. Moreover, candidate miRNAs as molecular hypotheses underpinning the associations were listed to guide future experiments. The predicted results were released for further studies. We expect that this study will provide help in our understanding of drug-disease association prediction and in the roles of miRNAs in drug repositioning.

References

  1. Arthritis Rheum. 2010 May;62(5):1361-71 - PubMed
  2. Pharmacogenomics. 2010 May;11(5):629-32 - PubMed
  3. BMC Syst Biol. 2010;4 Suppl 1:S2 - PubMed
  4. Nucleic Acids Res. 2015 Jan;43(Database issue):D914-20 - PubMed
  5. Nature. 2009 Nov 12;462(7270):175-81 - PubMed
  6. RNA. 2003 Oct;9(10):1274-81 - PubMed
  7. Cell. 2004 Jan 9;116(1):5-7 - PubMed
  8. Cell. 2004 Jan 9;116(1):121-37 - PubMed
  9. Cell. 2004 Jan 23;116(2):281-97 - PubMed
  10. Nat Rev Drug Discov. 2004 Aug;3(8):673-83 - PubMed
  11. Am J Trop Med Hyg. 1975 Mar;24(2):174-8 - PubMed
  12. Science. 1997 Jan 17;275(5298):343-9 - PubMed
  13. Curr Opin Struct Biol. 2005 Jun;15(3):331-41 - PubMed
  14. Nat Rev Cancer. 2006 Apr;6(4):259-69 - PubMed
  15. Mol Syst Biol. 2006;2:46 - PubMed
  16. Science. 2006 Sep 29;313(5795):1929-35 - PubMed
  17. ChemMedChem. 2006 Oct;1(10):1066-8 - PubMed
  18. Cancer Cell. 2006 Oct;10(4):331-42 - PubMed
  19. Drug Discov Today. 2007 Mar;12(5-6):225-33 - PubMed
  20. Chem Biol. 2007 Nov;14(11):1207-14 - PubMed
  21. Circ Res. 2007 Dec 7;101(12):1225-36 - PubMed
  22. Science. 2008 Jul 11;321(5886):263-6 - PubMed
  23. Nat Chem Biol. 2008 Nov;4(11):682-90 - PubMed
  24. PLoS Comput Biol. 2009 Jul;5(7):e1000423 - PubMed
  25. PLoS One. 2009;4(8):e6536 - PubMed
  26. Clin Pharmacol Ther. 2009 Nov;86(5):507-10 - PubMed
  27. Biochem Biophys Res Commun. 2010 Jun 11;396(4):989-93 - PubMed
  28. Proc Natl Acad Sci U S A. 2010 Aug 17;107(33):14621-6 - PubMed
  29. Brief Bioinform. 2011 Jul;12(4):303-11 - PubMed
  30. Biopharm Drug Dispos. 2011 Sep;32(6):355-67 - PubMed
  31. Oncol Rep. 2012 Jan;27(1):10-6 - PubMed
  32. Annu Rev Pharmacol Toxicol. 2012;52:361-79 - PubMed
  33. Sci Rep. 2012;2:318 - PubMed
  34. PLoS One. 2012;7(8):e43425 - PubMed
  35. Bioinformatics. 2013 Feb 1;29(3):409-11 - PubMed
  36. Mol Biosyst. 2013 Jun;9(6):1268-81 - PubMed
  37. Nat Rev Drug Discov. 2013 Nov;12(11):847-65 - PubMed
  38. Nucleic Acids Res. 2014 Jan;42(Database issue):D1070-4 - PubMed
  39. PLoS One. 2014;9(1):e84408 - PubMed
  40. PLoS Comput Biol. 2010 Feb;6(2):e1000662 - PubMed
  41. Clin Pharmacol Ther. 2010 Jun;87(6):754-8 - PubMed

Substances

MeSH terms

Publication Types